Mechanisms of sex differences in atrial fibrillation: role of hormones and differences in electrophysiology, structure, function, and remodelling.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
01 Mar 2019
Historique:
received: 17 05 2018
accepted: 03 09 2018
pubmed: 24 10 2018
medline: 22 9 2020
entrez: 24 10 2018
Statut: ppublish

Résumé

Atrial fibrillation (AF) is the clinically most prevalent rhythm disorder with large impact on quality of life and increased risk for hospitalizations and mortality in both men and women. In recent years, knowledge regarding epidemiology, risk factors, and patho-physiological mechanisms of AF has greatly increased. Sex differences have been identified in the prevalence, clinical presentation, associated comorbidities, and therapy outcomes of AF. Although it is known that age-related prevalence of AF is lower in women than in men, women have worse and often atypical symptoms and worse quality of life as well as a higher risk for adverse events such as stroke and death associated with AF. In this review, we evaluate what is known about sex differences in AF mechanisms-covering structural, electrophysiological, and hormonal factors-and underscore areas of knowledge gaps for future studies. Increasing our understanding of mechanisms accounting for these sex differences in AF is important both for prognostic purposes and the optimization of (targeted, mechanism-based, and sex-specific) therapeutic approaches.

Identifiants

pubmed: 30351414
pii: 5142404
doi: 10.1093/europace/euy215
doi:

Substances chimiques

Gonadal Steroid Hormones 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

366-376

Subventions

Organisme : British Heart Foundation
ID : RG/16/3/32175
Pays : United Kingdom

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Auteurs

Katja E Odening (KE)

Department of Cardiology and Angiology I, Heart Center, University of Freiburg, Hugstetter Str. 55, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, HX Maastricht, The Netherlands.

Sebastian Deiß (S)

Asklepios Medical Center Altona, Department of Cardiology, Arrhythmia Unit, Hamburg, Germany.

Dagmara Dilling-Boer (D)

Hartcentrum Hasselt, Jessa Ziekenhuis Hasselt, Hasselt, Belgium.

Maxim Didenko (M)

Department of Surgical and Interventional Arrhythmology, Kuprianov's Cardiovascular Surgery Clinic, Military Medical Academy, St. Petersburg, Russia.

Urs Eriksson (U)

Rhythmology Division, Department of Medicine, GZO Regional Health Center, Wetzikon, Switzerland.
Cardioimmunology, Center for Molecular Cardiology, University of Zurich, Zurich-Schlieren, Switzerland.

Sotirios Nedios (S)

Heart Center, University of Leipzig, Leipzig, Germany.
Massachusetts General Hospital, Harvard University, Boston, MA, USA.

Fu Siong Ng (FS)

National Heart & Lung Institute, Imperial College London, London, UK.

Ivo Roca Luque (I)

Arrhythmia Unit, Cardiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Pepa Sanchez Borque (P)

Fundacion Jimenez Diaz - Quiron Salud, Madrid, Spain.

Kevin Vernooy (K)

Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, HX Maastricht, The Netherlands.
Department of Cardiology, Radboud University Medical Center, GA Nijmegen, The Netherlands.

Adrianus P Wijnmaalen (AP)

Department of Cardiology, Leiden University Medical Center, ZA Leiden, The Netherlands.

Hikmet Yorgun (H)

Department of Cardiology, Electrophysiology Unit, Hacettepe University, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH